课题基金 / 基金详情

GENERAL SYNTHETIC APPROACH TOWARDS THE ANGUCYCLINES

GENERAL SYNTHETIC APPROACH TOWARDS THE ANGUCYCLINES
安古环素的一般合成方法
批准号:
2429351
负责人:
Theodore M Kamenecka
金额:
$2.37万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-06-01 至

项目摘要

项目成果

Theodore M Kamenecka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
An enantioselective and stereoselective synthesis of the angucycline antibiotics of the "aquayamycin-type" is proposed, including synthesis of the aglycone aquayamycin. Preparation of a key tetracyclic intermediate allows for a flexible approach to all members of this family through selective C- and O-glycosylation reactions. A mild acid catalyzed cyclization constructs the tetracyclic benz[a]anthracene core in enantiomerically pure form following a Schultz-type Birch reduction/alkylation sequence. Most of the angucylines show a wide array of biological activity, including antitumor, antibacterial and antiviral activity, as well as being enzyme inhibitors and inhibitors of blood platelet aggregation. Although nearly thirty antibiotics in this family share the same aglycone aquayamycin, to date, no synthesis has been reported.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
  • 批准号:
    10355649
  • 项目类别:
  • 资助金额:
    $18.54万
  • 财政年份:
    2021
  • 负责人:
    Theodore M Kamenecka
  • 依托单位:
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
  • 批准号:
    10595848
  • 项目类别:
  • 资助金额:
    $22.94万
  • 财政年份:
    2021
  • 负责人:
    Theodore M Kamenecka
  • 依托单位:
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
  • 批准号:
    10704368
  • 项目类别:
  • 资助金额:
    $49.8万
  • 财政年份:
    2021
  • 负责人:
    Theodore M Kamenecka
  • 依托单位:
Development of novel therapeutics for opioid dependence
海外基金